Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 6, 2023
0Patent Application Number
171047390
Date Filed
November 25, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
The present disclosure relates to methods and compositions for treating cancer with a diaryl macrocycle in combination with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2; MAP2K1 and MAP2K2), such as trametinib.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
